New Lung Cancer Drug Trial
Dr. Suresh Ramalingam on the details of a phase three trial of the drug crizotinib for treatment of a specific type of non-small cell lung cancer. The treatment would either be in addition or possibly as a replacement for chemotherapy. Ramalingam is with the Winship Cancer Institute of Emory University, one of the sites of a national research trial. Trial sponsor is the drug's producer, Pfizer. Suresh Ramalingam, MD, is an Associate Professor, Winship Cancer Institute, Emory University School of Medicine. He is also Director, Medical Oncology Department of Hematology and Medical Oncology.
"New Lung Cancer Drug Trial"
3 min. 19 sec.
"The Future of Lung Cancer Treatment"
3 min. 57 sec.
"A Better Way to Treat Lung Cancer"
1 min. 54 sec.